Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features

A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences

Kimura, M. (1980) · Journal of Molecular Evolution · doi:10.1007/bf01731581 · Cited by 29,778

Simultaneous Statistical Inference

Miller, R. G. (1981) · Springer series in statistics · doi:10.1007/978-1-4613-8122-8 · Cited by 5,608

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463

Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations

Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,559

Fundamentals of molecular evolution

(1991) · Journal of Human Evolution · doi:10.1016/0047-2484(91)90069-8 · Cited by 1,669

Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers

Kaghad, M., Bonnet, H., Yang, A., Créancier, L., Biscan, J.-C., Valent, A., Minty, A. J., Chalon, P., Lélias, J.-M., Dumont, X., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80540-1 · Cited by 1,659

Mutational hot spot in the p53 gene in human hepatocellular carcinomas

Hsu, I., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,533

A workbench for multiple alignment construction and analysis

Schuler, G. D., Altschul, S. F., & Lipman, D. J. (1991) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340090304 · Cited by 985

p73 is a human p53-related protein that can induce apoptosis

Jost, C. A., Marin, M. C., & Jr, W. G. K. (1997) · Nature · doi:10.1038/38298 · Cited by 948

RIBBONS 2.0

Carson, M. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891007240 · Cited by 809

Rare Somatic p53 Mutation Identified in Breast Cancer: A Case Report

Šmardová, J., Nemajerová, A., ek, M. T. S., Vagunda, V., & k, J. K. R. I. (2001) · Tumor Biology · doi:10.1159/000050597 · Cited by 25

Ultrasensitive Detection of DNA Based on Exonuclease III-Assisted Recycling Amplification and DNAzyme Motor

Mu, Q., Liu, G., Yang, D., Kou, X., Cao, N., Tang, Y., & Miao, P. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00774 · Cited by 24

Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations

Kim, J., Jeong, K., Jun, H., Kim, K., Bae, J. M., Song, M. G., Yi, H., Park, S., Woo, G.-U., Lee, D., et al. (2023) · Human Genomics · doi:10.1186/s40246-022-00447-3 · Cited by 26

Mislocalization of CDK11/PITSLRE, a regulator of the G2/M phase of the cell cycle, in Alzheimer disease

Bajić, V., Su, B., Lee, H., Kudo, W., Siedlak, S. L., Živković, L., Spremo‐Potparević, B., Djelić, N., Milićević, Z., Singh, A., et al. (2011) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-011-0011-2 · Cited by 24

Predicting the transactivation activity of p53 missense mutants using a four-body potential score derived from Delaunay tessellations

Mathé, E. A., Olivier, M., Kato, S., Ishioka, C., Vaisman, I. I., & Hainaut, P. L. (2006) · Human Mutation · doi:10.1002/humu.20284 · Cited by 24

Mutation identification DNA analysis system (MIDAS) for detection of known mutations

Bazar, L. S., Collier, G. B., Vanek, P. G., Siles, B. A., Kow, Y. W., Doetsch, P. W., Cunningham, R. P., & Chirikjian, J. G. (1999) · Electrophoresis · doi:10.1002/(sici)1522-2683(19990101)20:6 · Cited by 15

Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.

Baumbusch, L. O., Myhre, S., Langerød, A., Bergamaschi, A., Geisler, S. B., Lønning, P. E., Deppert, W., Dornreiter, I., & Børresen‐Dale, A. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-47 · Cited by 23

Structural prediction of protein interactions and docking using conservation and coevolution

Andréani, J., Quignot, C., & Guérois, R. (2020) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1470 · Cited by 23

Identifying Functionally Important Mutations from Phenotypically Diverse Sequence Data

Jensen, K. L., Alper, H. S., Fischer, C. R., & Stephanopoulos, G. N. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.5.3696-3701.2006 · Cited by 21

p53 Expression as a marker of microinvasion in oral squamous cell carcinoma.

Heah, K. G., Hassan, M. I. A., & Huat, S. C. (2011) · PubMed · Cited by 21

Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin

Bendig, I., Mohr, N., Krämer, F., & Weber, B. H. F. (2004) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2004.02.017 · Cited by 21

Base damage, local sequence context andTP53mutation hotspots: a molecular dynamics study of benzo[a]pyrene induced DNA distortion and mutability

Menzies, G. E., Reed, S. H., Brancale, A., & Lewis, P. D. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv910 · Cited by 20

ATM deficiency augments constitutively nuclear cyclin D1-driven genomic instability and lymphomagenesis

Vaites, L. P., Lian, Z., Lee, E. K., Yin, B., DeMicco, A., Bassing, C. H., & Diehl, J. A. (2013) · Oncogene · doi:10.1038/onc.2012.577 · Cited by 20

The Gain of Function of p53 Mutant p53S in Promoting Tumorigenesis by Cross-talking with H-RasV12

Jia, S., Zhao, L., Tang, W., & Luo, Y. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4176 · Cited by 21

Stable production of peptide antigens in transgenic tobacco chloroplasts by fusion to the p53 tetramerisation domain

Ortigosa, S. M., Millán, A. F., & Veramendi, J. (2009) · Transgenic Research · doi:10.1007/s11248-009-9348-y · Cited by 19

Computational analysis of mutation spectra

Rogozin, I. B. (2003) · Briefings in Bioinformatics · doi:10.1093/bib/4.3.210 · Cited by 17

Synergism of CPT-11 and Apo2L/TRAIL against Two Differentially Sensitive Human Colon Tumor Xenografts

Sugamura, K., Gibbs, J. F., Belicha‐Villanueva, A., Andrews, C., Repasky, E. A., & Hylander, B. L. (2008) · Oncology · doi:10.1159/000151366 · Cited by 17

Towards fast and inexpensive molecular diagnostic: the case of TP53

Jiang, T., Minunni, M., & Mascini, M. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.01.018 · Cited by 17

Comparative analysis of germline and somatic microlesion mutational spectra in 17 human tumor suppressor genes

Ivanov, D. K., Hamby, S. E., Stenson, P. D., Phillips, A. D., Kehrer-Sawatzki, H., Cooper, D. N., & Chuzhanova, N. A. (2011) · Human Mutation · doi:10.1002/humu.21483 · Cited by 16

PCR-Based Simple Subgrouping Is Validated for Classification of Gliomas and Defines Negative Prognostic Copy Number Aberrations in IDH Mutant Gliomas

Nakae, S., Sasaki, H., Hayashi, S., Hattori, N., Kumon, M., Nishiyama, Y., Adachi, K., Nagahisa, S., Hayashi, T., Inamasu, J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142750 · Cited by 16

Multimerization of peptide antigens for production of stable immunogens in transgenic plants

Gil-Dones, F., Reytor, E., Pérez-Filgueira, D. M., & Escribano, J. M. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.11.001 · Cited by 15

Functional study of novel PAX9 variants: The paired domain and non‐syndromic oligodontia

Sun, K., Yu, M., Yeh, I., Zhang, L., Liu, H., Cai, T., Feng, H., Liu, Y., & Han, D. K. (2020) · Oral Diseases · doi:10.1111/odi.13684 · Cited by 15

Functional impacts of non‐synonymous single nucleotide polymorphisms: Selective constraint and structural environments

Bao, L., & Cui, Y. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.01.035 · Cited by 14

Identification of Hot and Cold spots in genome of Mycobacterium tuberculosis using Shewhart Control Charts

Das, S., Duggal, P., Roy, R., Myneedu, V. P., Behera, D., Prasad, H. K., & Bhattacharya, A. (2012) · Scientific Reports · doi:10.1038/srep00297 · Cited by 14

Biochemical and Functional Evidence of p53 Homology Is Inconsistent with Molecular Phylogenetics for Distant Sequences

Fernandes, A. D., & Atchley, W. R. (2008) · Journal of Molecular Evolution · doi:10.1007/s00239-008-9124-2 · Cited by 14

Early modification of c-myc, Ha-ras and p53 expressions by N-methyl-N-nitrosourea.

Budán, F., Varjas, T., Nowrasteh, G., Varga, Z., Boncz, I., Cseh, J., Prantner, I., Tibold, A., Pázsit, E., Göbel, G., et al. (2008) · PubMed · Cited by 13

A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo

Comiskey, D. F., Jacob, A. G., Sanford, B. L., Montes, M., Goodwin, A., Steiner, H. E., Matsa, E., Tapia-Santos, A. S., Bebee, T. W., Grieves, J. L., et al. (2017) · Oncogene · doi:10.1038/onc.2017.282 · Cited by 13

Molecular Mechanisms of Carcinogenesis

Malejka‐Giganti, D., & Tretyakova, N. Y. (2005) · Chemical and functional properties of food components series · doi:10.1201/9781420039269.ch2 · Cited by 12

Low density DNA microarray for detection of most frequent TP53 missense point mutations

Rangel-López, A., Maldonado‐Rodríguez, R., Salcedo–Vargas, M., Espinosa-Lara, J. M., Méndez-Tenorio, A., & Beattie, K. L. (2005) · BMC Biotechnology · doi:10.1186/1472-6750-5-8 · Cited by 13

Defining relative mutational difficulty to understand cancer formation

Shan, L., Yu, J., He, Z., Chen, S., Liu, M., Ding, H., Xu, L., Zhao, J., Yang, A. E., & Jiang, H. (2020) · Cell Discovery · doi:10.1038/s41421-020-0177-8 · Cited by 10

Oxidatively generated DNA damage induced by 3-amino-5-mercapto-1,2,4-triazole, a metabolite of carcinogenic amitrole

Furukawa, A., Oikawa, S., Harada, K., Sugiyama, H., Hiraku, Y., Murata, M., Shimada, A., & Kawanishi, S. (2010) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2010.08.004 · Cited by 12

Adaptive patterns in the p53 protein sequence of the hypoxia- and cancer-tolerant blind mole rat Spalax

Domankevich, V., Opatowsky, Y., Malik, A., Korol, A. B., Frenkel, Z., Manov, I., Avivi, A., & Shams, I. (2016) · BMC Evolutionary Biology · doi:10.1186/s12862-016-0743-8 · Cited by 11

Coexpression and nuclear colocalization of metastasis-promoting protein S100A4 and p53 without mutual regulation in colorectal carcinoma

Berge, G., Costea, D. E., Berg, M., Rasmussen, H., Grotterød, I., Lothe, R. A., Mælandsmo, G. M., & Flatmark, K. (2010) · Amino Acids · doi:10.1007/s00726-010-0514-6 · Cited by 12

Complete Models of p53 Better Inform the Impact of Hotspot Mutations

Solares, M. J., & Kelly, D. F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315267 · Cited by 11

Gain of function in the mouse model of a recurrent mutation p53N236S promotes the formation of double minute chromosomes and the oncogenic potential of p19ARF

Zhao, L., Wang, B., Zhao, X., Wu, X., Zhang, Q., Wei, C., Shi, M.-L., Li, Y., Tang, W., Zhang, J., et al. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22737 · Cited by 11

Mutational hotspots in the TP53gene and, possibly, other tumor suppressors evolve by positive selection

Glazko, G. V., Babenko, V. N., Koonin, E. V., & Rogozin, I. B. (2006) · Biology Direct · doi:10.1186/1745-6150-1-4 · Cited by 11

Damage to cellular and isolated DNA induced by a metabolite of aspirin

Oikawa, S., Kobayashi, H., Tada‐Oikawa, S., Isono, Y., & Kawanishi, S. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.11.016 · Cited by 11

Remote intracranial recurrence of IDH mutant gliomas is associated with TP53 mutations and an 8q gain

Nakae, S., Kato, T., Murayama, K., Sasaki, H., Abe, M., Kumon, M., Kumai, T., Yamashiro, K., Inamasu, J., Hasegawa, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20951 · Cited by 10

Analysis of TP53 germline mutations in pediatric tumor patients using DNA microarray-based sequencing technology

Schaefer, K., Wai, D., Poremba, C., Diallo, R. I., Boecker, W., & Dockhorn‐Dworniczak, B. (2002) · Medical and Pediatric Oncology · doi:10.1002/mpo.10044 · Cited by 10

Maximum likelihood analysis of mammalian p53 indicates the presence of positively selected sites and higher tumorigenic mutations in purifying sites

Maola, K. M. G., Rydén, A., Chowdhury, M. S., Hasan, M. A., & Kazi, J. U. (2011) · Gene · doi:10.1016/j.gene.2011.05.011 · Cited by 9

Modeling the Etiology of p53-mutated Cancer Cells

Perez, R. E., Shen, H., Duan, L., Kim, R. H., Kim, T., Park, N.-H., & Maki, C. G. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.724781 · Cited by 9

A new deep learning technique reveals the exclusive functional contributions of individual cancer mutations

Gupta, P., Jindal, A., Ahuja, G., Jayadeva, & Sengupta, D. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102177 · Cited by 10

Frequency and features ofTP53mutation in 30 Chinese patients with sporadic basal cell carcinoma

Wang, Y. M., Huang, Y. S., H., Z., Bu, D., Wang, Y., Tu, P., & Li, H. (2014) · Clinical and Experimental Dermatology · doi:10.1111/ced.12411 · Cited by 9

Theory and Therapy: On the Conceptual Structure of Models in Medical Research

CARRIER, M. J., & Finzer, P. (2010) · Boston studies in the philosophy of science · doi:10.1007/978-90-481-9051-5_6 · Cited by 9

New developments in small molecules targeting p53 pathways in anticancer therapy

Cheok, C. F., & Lane, D. P. (2008) · Drug Development Research · doi:10.1002/ddr.20261 · Cited by 8

Four Novel PAX9 Variants and the PAX9-Related Non-Syndromic Tooth Agenesis Patterns

Liu, H., Liu, H., Su, L., Zheng, J., Feng, H., Liu, Y., Yu, M., & Han, D. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158142 · Cited by 8

In vivo effects of afobazole (2-mercaptobenzimidazole derivative) on the 7,12-dimethylbenz [alpha]anthracene-induced oncogene and suppressor gene expression.

Szanyi, I., Lujber, L., Gerlinger, I., Pytel, J., Bauer, M., Csejtei, A., Szele, E., Gombos, K., Kiss, I., Середенин, С. Б., et al. (2007) · PubMed · Cited by 8

Two different, mutually exclusively distributed, TP53 mutations in ovarian and peritoneal tumor tissues of a serous ovarian cancer patient: indicative for tumor origin?Preprint

Sukhbaatar, N., Bachmayr-Heyda, A., Auer, K., Aust, S., Deycmar, S., Horvat, R., & Pils, D. (2017) · Molecular Case Studies · doi:10.1101/mcs.a001461 · Cited by 8

A hotspot in the glucocorticoid receptor DNA-binding domain susceptible to loss of function mutation

Banuelos, J., Shin, S. C., & Lu, N. Z. (2015) · Steroids · doi:10.1016/j.steroids.2015.01.022 · Cited by 7

PROGNOSTIC STATUS OF p53 PROTEIN ACCUMULATION IN CANINE MALIGNANT MAMMARY TUMOURS

Łopuszyński, W., Szczubiał, M., & Komsta, R. (2010) · Cited by 7

Synergistic interaction between the novel histone deacetylase inhibitor ST2782 and the proteasome inhibitor bortezomib in platinum-sensitive and resistant ovarian carcinoma cells

Gatti, L., Benedetti, V., Cesare, M. D., Corna, E., Cincinelli, R., Zaffaroni, N., Zunino, F., & Perego, P. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.04.007 · Cited by 7

Evolutionary conservation and mutational spectrum of BMPR2 gene

Wong, W. K. P., Morse, J. H., & Knowles, J. A. (2005) · Gene · doi:10.1016/j.gene.2005.10.025 · Cited by 6

Immunohistochemical expression of protein p53 in neoplasms of the mammary gland in bitches.

Rodo, A., & Malicka, E. (2008) · PubMed · Cited by 6

A novel seven-tier framework for the classification of MEFV missense variants using adaptive and rigid classifiers

Alay, M. T. (2025) · Scientific Reports · doi:10.1038/s41598-025-94142-7 · Cited by 5

Kooperative Bindung von p53 an DNA: Regulation durch Protein‐Protein‐Wechselwirkung unter Bildung einer doppelten Salzbrücke

Dehner, A., Klein, C., Hansen, S., Müller, L., Büchner, J., Schwaiger, M., & Kessler, H. (2005) · Angewandte Chemie · doi:10.1002/ange.200501887 · Cited by 5

Metal oxide semiconductor field-effect transistor (MOSFET)-based direct monitoring of p53 in spiked serum

Oh, Y., Dung, T. T., Lee, Y., Lee, C., & Kim, M. (2016) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2016.03.015 · Cited by 4

Mechanism of Oxidative DNA Damage Induced by Environmental Carcinogens and Antioxidants

Oikawa, S. (2008) · Genes and Environment · doi:10.3123/jemsge.30.1 · Cited by 4

Chemical Carcinogenesis

Hofseth, L. J., Weston, A., & Harris, C. C. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm023.pub2 · Cited by 4

Aberrant p53 protein expression and function in a panel of hematopoietic cell lines with different p53 mutations

Kamihira, S., Terada, C., Sasaki, D., Yanagihara, K., Tsukasaki, K., Hasegawa, H., & Yamada, Y. (2009) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2009.01211.x · Cited by 3

On the complexity measures of mutation hotspots in human TP53 protein

Ding, Y., Xue, H., Ding, X., Zhao, Y., Zhao, Z., Wang, D., & Wu, J. (2020) · Chaos An Interdisciplinary Journal of Nonlinear Science · doi:10.1063/1.5143584 · Cited by 3

Changes in expression of oncogenes and TP53 tumour suppressor gene as biomarkers in head and neck cancers

Szanyi, I., Bauer, M., Gerlinger, I., Járai, T., Göbel, G., Lujber, L., Szabadi, É., Fehér, K., Ember, Á., Ember, I., et al. (2010) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-010-1425-6 · Cited by 3

Pre-UV-Treatment of Cells Results in Enhanced Host Cell Reactivation of a UV Damaged Reporter Gene in CHO-AA8 Chinese Hamster Ovary Cells but Not in Transcription-Coupled Repair Deficient CHO-UV61 Cells

Liu, L., & Rainbow, A. J. (2004) · Bioscience Reports · doi:10.1007/s10540-005-2792-x · Cited by 3

Online tool for the discrimination of equi-distributions

Pöschel, T., Frömmel, C., & Gille, C. (2003) · BMC Bioinformatics · doi:10.1186/1471-2105-4-58 · Cited by 3

Results of p53 analysis in pediatric malignancies in Poland

Fiszer‐Maliszewska, Ł., Czernik, J., Sawicz-Birkowska, K., Kazanowska, B. J., & Wojciechowska, B. (2003) · Medical and Pediatric Oncology · doi:10.1002/mpo.10277 · Cited by 3

Single‐cell immunohistochemical mutation load assay (SCIMLA) using human paraffin‐embedded tissues

Schlake, G., Liu, Q., Heinmöller, E., Hill, K. A., Weiss, L. M., & Sommer, S. S. (2003) · Environmental and Molecular Mutagenesis · doi:10.1002/em.10193 · Cited by 3

Brain Metastases Are Regulated by Immuno-inflammatory Signaling Pathways Governed by STAT3, MAPK and Tumor Suppressor p53 Status: Possible Therapeutic Targets

Zeller, S., Spirollari, E., Dicpinigaitis, A. J., Wainwright, J. V., Hanft, S. J., Gandhi, C. D., & Jhanwar‐Uniyal, M. (2023) · Anticancer Research · doi:10.21873/anticanres.16783 · Cited by 2

Functional Analysis of the Human p53 Tumor Suppressor and its Mutants Using Yeast

Inga, A., Storici, F., & Resnick, M. A. (2007) · Springer eBooks · doi:10.1007/978-1-4020-5963-6_10 · Cited by 2

Novel MSX1 Gene Variants in Chinese Children with Non-Syndromic Tooth Agenesis: A Clinical and Genetic Analysis

Ding, T., Liu, H., & Yu, G. (2024) · Children · doi:10.3390/children11121418 · Cited by 1

NCI 10211: a phase II, single-arm study of berzosertib in combination with irinotecan in patients with advanced TP53 mutant gastroesophageal cancer

Wheless, M. C., Stockton, S. S., Soares, H. P., Dayyani, F., Saeed, A., Kim, E. J.-H., Jin, N., Yacoub, G., Florou, V., Ayers, G. D., et al. (2025) · The Oncologist · doi:10.1093/oncolo/oyaf400 · Cited by 1

Adenovirus mediated gene therapy in cell lines derived from canine oral melanoma

Rodrigues, O. A., Antunes, F., Silva, G. R. O., Niitsuma, B. N., da Luz, J. C. D. S., & Strauss, B. E. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1835389 · Cited by 1

Pan-cancer analysis of expressed somatic nucleotide variants in long intergenic non-coding RNA

Ching, T., & Garmire, L. (2018) · Pacific Symposium on Biocomputing · doi:10.1142/9789813235533_0047 · Cited by 1

Analysis of TP53 Gene Mutations in the Korean Patients with Lung Cancer

Jung, S. B., Chang, H. K., Choi, S. C., Shin, K. C., Lee, K.-H., & Jeon, C. (2011) · Laboratory Medicine Online · doi:10.3343/lmo.2011.1.4.6 · Cited by 1

Relationships of clinical response to relevant molecular signal during Phase I testing of Aurora Kinase A inhibitor: Retrospective assessment

Nemunaitis, J. J., Blend, C., Bien-Willner, G. A., Degele, M., Roth, A., Hayes, S., Plato, L., Guo, A. Y., Nemunaitis, J., Jackson, D., et al. (2015) · Integrative Molecular Medicine · doi:10.15761/imm.1000162 · Cited by 1

Es la muerte importante para la vida

Pérez, F., & Fernando, I. (2002) · Veterinaria · Cited by 1

Estabelecimento de linhagens celulares de melanoma canino e transdução com vetores adenovirais aprimorados

Silva, G. R. O. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2019.tde-07052019-103754 · Cited by 1

Models Predicting Effects of Missense Mutations in Oncogenesis

Addepalli, K. (2014) · doi:10.13021/mars/7671 · Cited by 1

Efeito do fator de necrose tumoral-alfa (TNF-α)sobre células imortalizadas por papilomavírus humano (HPV)

Pierulivo, E. M. B. (2002) · doi:10.11606/t.46.2002.tde-06022009-150450

Prostate-specific expression of p53(R172L) differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival.

Hernández, I., Maddison, L. A., Wei, Y., DeMayo, F. J., Petras, T., Li, B., Gingrich, J. R., Rosen, J. M., & Greenberg, N. M. (2003) · PubMed · Cited by 32

The detection and role of human endogenous retroviruses in multiple sclerosis and other neurological diseases

Smith, R. G. (2009) · Wolverhampton Intellectual Repository and E-Theses (University of Wolverhampton)

REGULATION OF DNA DAMAGE PROCESSING BY COVALENT MODIFICATION OF THYMINE DNA GLYCOSYLASE (Spine title: Regulation of DNA damage processing by thymine DNA glycosylase) (Thesis format: Integrated-Article)

Mohan, R. D. (2010)

Granular Association Testing in p53 Multiple Sequence Alignment

Manjunath, R. (2012) · The Atrium (University of Guelph)

Estudo comparativo da imunomarcação da p53 em carcinomas epidermóides bucais de sítios anatômicos diferentes

Cabral, C. T. S. (2004) · Americanae (AECID Library)

Protein Folding: From Normal Cellular Function to Pathophysiology

Rasool, M., Malik, A., Manan, A., Sultana, M., Qazi, M. H., & Pushparaj, P. N. (2015) · Springer eBooks · doi:10.1007/978-81-322-2467-9_5

Uncovering p53 Mutations and Abnormal Gene Expression in Pediatric Adrenocortical Cancer

West, A. N. (2007) · doi:10.21007/etd.cghs.2007.0347

Online tool for the discrimination of equi-distributionsPreprint

Poeschel, T., Frömmel, C., & Gille, C. (2004) · arXiv (Cornell University) · doi:10.48550/arxiv.q-bio/0401041

Mutational evaluation of TP53 gene in the canine hepatocellular carcinoma: a comparative approach

Gómez, D. S. (2019) · doi:10.11606/d.10.2019.tde-09092019-094659

Zusammenhänge zwischen TP53-Mutationsstatus, genetischer Instabilität und Prognose bei MDS und sekundärer AML mit komplex aberrantem Karyotyp

Schaab, R. (2020) · doi:10.53846/goediss-7883

Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutationsPreprint

Kim, J., Jeong, K., Jun, H., Kim, K., Yi, H., Park, S., Woo, G.-U., Lee, D., Kim, T.-Y., Lee, K.-H., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1942928/v1

Supplementary Results from High Incidence of Protein-Truncating TP53 Mutations in BRCA1-Related Breast Cancer

Holstege, H. H., Joosse, S. A., van Oostrom, C. T. M., Nederlof, P. M., de Vries, A., & Jonkers, J. (2023) · doi:10.1158/0008-5472.22380516

Supplementary Results from High Incidence of Protein-Truncating TP53 Mutations in BRCA1-Related Breast Cancer

Holstege, H. H., Joosse, S. A., van Oostrom, C. T. M., Nederlof, P. M., de Vries, A., & Jonkers, J. (2023) · doi:10.1158/0008-5472.22380516.v1

Resolving p53 to Create Clinically-Relevant Mutation Models

Solares, M. J., Jonaid, G. M., & Kelly, D. F. (2023) · Microscopy and Microanalysis · doi:10.1093/micmic/ozad067.560

Chemical Carcinogenesis

Hofseth, L. J., Weston, A., & Harris, C. C. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm023

Gain-of-function mutant p53 regulates long-noncoding RNA LINC00643 to modulate HIF1α in glioblastomaPreprint

Zhang, Y., Yuan, F., Gibert, M. K., Dube, C., Hudson, K., Grello, C., Reon, B. J., Saha, S., Sun, Y., Marcinkiewicz, P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.16.676559

Mechanistic insights into NFIX frameshift mutations in Malan syndrome: proteasomal degradation-mediated haploinsufficiency

Zhou, Y., Zou, L., & Li, Y. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1648420

BRAP Promotes the Tumorigenesis of Hepatocellular Carcinoma by Corrupting Cancer Cell Cycle Regulation and Enhancing Immune Evasion

Guo, Y., Gu, R., Gao, F., Liu, L., Deng, D., Zhang, Q., Wang, L., Liu, Q., Lan, L., & Cang, S. (2025) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s547105

Additional file 1 of Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations

Kim, J., Jeong, K., Jun, H., Kim, K., Bae, J. M., Song, M. G., Yi, H., Park, S., 우고운, Lee, D.-W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26559497

Exploration and structural modelling of protein interactions using evolutionary information

Quignot, C. (2020) · theses.fr (ABES) · doi:10.70675/c93aba27zbff8z4080za06cze186c92097dc

Mutation hotspots in the p53 gene in tumors of different origin: correlation with evolutionary conservation and signs of positive selection

Glazko, G. V., Koonin, E. V., & Rogozin, I. B. (2004) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2004.05.004 · Cited by 28

Evolutionary Conservation and Functional Constraint of TP53 Mutation Hotspots Across Mammalian SpeciesPreprint

Rawat¹, R. R., Nadar, S., & Uppal, G. K. (2026) · Research Square · doi:10.21203/rs.3.rs-9299199/v1

Mutational Hotspots and Conserved Domains in P53 Tumour Suppressor ProteinPreprint

Omotoso, O. E. (2020) · Preprints.org · doi:10.20944/preprints202008.0562.v1 · Cited by 1

Detailed computational study of p53 and p16: using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants

Greenblatt, M. S., Beaudet, J. G., Gump, J., Godin, K. S., Trombley, L. M., Koh, J., & Bond, J. P. (2003) · Oncogene · doi:10.1038/sj.onc.1206101 · Cited by 76

The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spotsPreprint

Pavletich, N., Chambers, K., & Pabo, C. (1993) · HighWire Press Open Archive · doi:10.1101/gad.7.12.2556